Wrexham Community Mental Health Team, 16 Grosvenor Road, Wrexham LL11 1BU, email: giles.harborne{at}new-tr.wales.nhs.uk
Llwyn-y-Groes Psychiatric Unit, Wrexham
G.H. and A.J. have received unrestricted travel and educational grants from Eli Lilly and Janssen.
|
|
|---|
To describe the implementation of supplementary prescribing and nurse-led care in an acute in-patient unit. The issues of delegation and distribution of responsibility were explicitly addressed. Structures were developed for training and supervision, to ensure improved medicines management in the acute setting.
RESULTS
We present our five-step model of nurse-led in-patient care and our experience of using a clinical management plan for 33 patients.
CLINICAL IMPLICATIONS
Implementation of supplementary prescribing provides a model for new ways of working, requiring engagement of both doctors and nurses, clear delegation and distribution of responsibilities, and well-developed governance structures.
|
|
|---|
Prescribing is no longer a solely medical task, we now have patient group directives, supplementary prescribing and lately independent nurse prescribing (Department of Health, 2006a). Supplementary prescribing is a delegated responsibility, where the overall responsibility for patient management remains with the delegating doctor (General Medical Council, 2006), although the persons delegated to are accountable for their own decisions and actions. The delegating doctor has responsibilities to ensure communication about the patient and the treatment needed, and must ensure that the person delegated to has the necessary qualifications, experience, knowledge and skills.
Supplementary prescribing has the potential to improve patient outcome (National Prescribing Centre, 2005). However, there are acknowledged difficulties in implementation. Organisational barriers and lack of knowledge and confidence have been identified as causes of non-adoption of supplementary prescribing by trained nurse prescribers (Brimblecombe et al, 2005) as has the lack of supervisor support. Gray et al (2005) noted the need to explore further the knowledge, skills and confidence of psychiatrists undertaking a nurse prescribing supervision role.
Little has been written about supplementary prescribing from the psychiatrists perspective; implementation and research are nurse-led (Jones, 2006; Nolan et al, 2001). The impact on doctors, in terms of changes in the way of working and the training and supervision of prescribers, is barely mentioned in key documents (Department of Health, 2006b). Supplementary prescribing is repeatedly described as a voluntary partnership between an independent prescribing doctor and a supplementary prescribing nurse. However, a partnership assumes that both sides work towards a common aim, through an agreed process, on an equal footing. Clearly the prescribing relationship is not equal; the consultant has a depth and breadth of psychopharmacological knowledge and therapeutic experience unavailable to even the most experienced supplementary prescriber.
We have developed a model of acute in-patient care which both delegates responsibility for prescribing and distributes responsibility for assessment and care management. We offer some observations based on our experience.
|
|
|---|
Where do we prescribe?
Most community prescribing is carried out by general practitioners on the
advice of psychiatrists, the exceptions being crisis situations and long-term
depot or clozapine treatments. There is little incentive to take back work
from primary care where the infrastructure and governance arrangements are
well-established; this is contrary to the Director of Nursing survey
(National Prescribing Centre,
2005) which saw the community mental health team as the focus for
nurse prescribing. Most specialist prescribing occurs in in-patient settings,
an area of medicines management highlighted by the Health Care Commission
(2007) as needing urgent
improvement.
How could supplementary prescribing improve on the existing arrangements?
Medical time on the wards has reduced, consultants are more
community-focused and trainee time is disrupted by shift-working and the need
to gain community and psychotherapeutic training. Specialist pharmacists are
few in number and hard to recruit, and there is an increasing recognition of
the effectiveness of nurse-led care in delivering behavioural change and
medicines management (Gray et al,
2004).
How do we obtain the support for systems to change?
Our in-patient services had been through a 2-year refocusing process with a
number of consultants, teams and wards developing new, devolved and more
patient-focused ways of working. Consultants can be engaged in a teaching
capacity, and a number have gone on to supervise nurses through 72 h of
clinical practice as part of their prescribing course.
New way of working in an acute in-patient setting
Skilled expertise rests with the psychiatrist, but not all patients nor all
aspects of patient care necessarily require the skills of the psychiatrist. We
developed a five-step model where the prescribing responsibility was delegated
and the assessment and care management responsibility distributed from the
psychiatrist to the nurse consultant.
Developing the working relationships
The strength of the relationship lies in the psychiatrist being involved in
the supplementary prescribers training and ongoing personal development
including their supervision. This allows the doctor to be sure of knowing the
supplementary prescribers strengths and weakness, building trust and
understanding. The primary syllabus for supplementary prescribing is generic
to all areas of medicine, and there is an acknowledged gap in nurse education
regarding biological psychiatry (Gournay,
2005). Key to the change in working has been the adoption of joint
records, written in a shared language, with a shift from the nursing narrative
style to the more analytical and hypothesis driven medical style.
Consultants role
This has been an active change to standing back from acute patient contact
and the clinical processes on the wards, and taking on more supervision and
consultation work. This has raised issues of how this new way of working is
accounted for in terms of activity, job planning and governance. Patient
resistance, and a demand to regularly see the psychiatrist, have not been
encountered once the system was up and running.
The central role of the clinical management plan
This is the legally required written plan of treatment which delegates
prescribing authority; it is also an exercise in good medicines management.
Decision-making is openly shared with the patient, who must consent to the
plan. The evidence base is both noted in the plan and used by the
supplementary prescriber. Common reference points for us include the British
National Formulary, Maudsley Prescribing Guidelines
(Taylor et al, 2005)
and National Institute for Health and Clinical Excellence guidelines for the
treatment of schizophrenia (National
Institute for Health and Clinical Excellence, 2002) and mood
disorders (National Institute for Health
and Clinical Excellence, 2006). A care management plan requires a
clear working diagnosis, goals for treatment and a plan of the types of
treatments that would be offered with reasons for changing. This helps to
prevent situations where patients can be admitted with unclear goals, or the
discharge point slips as other issues intrude. Goals also help to define
target symptoms for tracking progress, and this brings the whole in-patient
nursing team into using the same parameters in their nursing record. The
supplementary prescriber and nursing team are also engaged in tracking
side-effects, imparting information and influencing behaviour for positive
concordance.
|
|
|---|
|
View this table: [in a new window] | Table 1. Types of care management plan |
|
|
|---|
|
|
|---|
Related articles in PB:
Read all eLetters
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||